Terpenicol Antifungal Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Terpenicol Antifungal Cream
Generic name
MICONAZOLE NITRATE
Manufacturer
Blaine Labs Inc.
Product type
HUMAN OTC DRUG
SPL set ID
9a4ec493-0b36-4bb8-aa9a-55cf5f79aeaa
SPL ID
47550d3c-e1eb-4369-a7b8-919913c431c8
Version
1
Effective date
2026-07-01
Source export date
2026-11-06
Source partition
11
Source file
https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/2233cb6af8c6b55a5e4a05449e8db0d2f259f3c061d5d001b654a8bea1cc1db2/drug-label-0011-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 07:53:50
Harmonized routes table
Harmonized routes
CUTANEOUS

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings - For external use only When using this product ■ Avoid contact with eyes: rinse immediately with cool tap water if contact occurs ■ Do not use for vaginal yeast infections ■ Do not use on children under 2 years of age unless directed by a doctor Stop use and ask a doctor If irritation occurs or if there is no improvement within 4 weeks (for athlete’s foot or ringworm)

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.